HopeStage
Back to all studies
Active Not RecruitingNCT06117306

MDMA-assisted Massed Prolonged Exposure for PTSD

Medication studyAges 18–64United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 64 years.

Listed locations
San DiegoSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 25, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
20
Sponsor
Healing Breakthrough
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT06117306
Official title
Show the full official title

MDMA-assisted Massed Prolonged Exposure for PTSD

Recruitment & locations

Not recruiting

San Diego

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Healing Breakthrough.

Does this study involve medication?

Yes. The study involves medication, including 3,4 Methylenedioxymethamphetamine.

Who can participate?

Listed age limits: 18 years to 64 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies